Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
Personalized Nutrition Market: 11.48% CAGR to 2033
Personalized Nutrition Market
Personalized Nutrition Market: 11.48% CAGR to 2033
Personalized Nutrition Market by Product Type (Active Measurement, Standard Measurement), by Application (Standard Supplement, Disease Based), by End Use (Direct-to-Consumer, Wellness and Fitness Centers, Hospital and Clinics, Institutions), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
Updated On : Sep 30, 2026|Base Year : 2025|Pages : 180
The global Personalized Nutrition Market closed 2025 at USD 22.55 billion and is projected to reach USD 53.79 billion by 2033, a 11.48% CAGR. Growth is uneven across the stack: active-measurement formats carrying biomarker panels, genetic trait analysis and microbiome sequencing compound at 13.2%, roughly 410 basis points ahead of non-measured supplement formats.
Personalized Nutrition Market Size (In Billion)
50.0B
40.0B
30.0B
20.0B
10.0B
0
22.55 B
2025
25.14 B
2026
28.02 B
2027
31.24 B
2028
34.83 B
2029
38.83 B
2030
43.28 B
2031
Three structural forces explain the acceleration:
Cost collapse in genotyping. Array and targeted sequencing now run USD 30-60 per sample at commercial volume, pushing consumer panel pricing below the USD 200 threshold across North America and Western Europe.
Retail repositioning. Grocery and pharmacy chains now dedicate planogram space to evidence-linked nutrition, moving the Personalized Nutrition Supplements Market from specialist e-commerce into mass distribution.
Data infrastructure maturity. The Digital Health and Wearables Market supplies continuous glucose, sleep and activity telemetry that feeds the recommendation engines underpinning subscription renewals.
Margin structure is bifurcated. Subscription programs with attached coaching deliver 60-72% gross margins, while private-label capsule fulfillment delivers 22-30%. Vendors owning both the measurement layer and the fulfillment layer capture the widest spread; those owning only fulfillment compete on unit price.
Downstream, the Functional Food and Beverages Market is the largest adjacent absorber of personalized formulations, with fortified beverages and protein blends taking a rising share of personalized SKUs.
Strategic takeaway: the 2025-2028 window rewards conversion of one-time genetic test purchases into multi-year subscription annuities. Median 12-month retention in DTC personalized nutrition sits near 34%, making retention, not acquisition, the binding constraint.
Segment Deep-Dive: Active Measurement Dominance in Personalized Nutrition Market
Segment Analysis Matrix
Segment
CAGR (2025-2033)
Market Share (2025)
Key Demand Driver
Active Measurement (Product Type)
13.2%
58.4%
At-home biomarker panels bundled with genetic and microbiome testing
Standard Measurement (Product Type)
9.1%
41.6%
Retail private-label expansion and price-sensitive repeat buyers
Disease Based (Application)
14.6%
22.3%
Clinical nutrition protocols for diabetes, cardiometabolic and oncology care
Why Active Measurement Leads
Active Measurement generated USD 13.17 billion in 2025, or 58.4% of total revenue. The segment monetizes twice: once at the test, again at the recurring supplement subscription. Three mechanics sustain the gap over standard formats:
Higher average order value. Measured customers spend 2.3x more in year one than non-measured buyers because a lab result creates an explicit product justification.
Lower churn. Panels that include quarterly retesting cut 12-month churn by an estimated 9-14 percentage points versus one-time test models.
Channel pull. Employer and clinic buyers require a documented measurement step, which excludes pure capsule vendors from procurement shortlists.
Sub-Segment Dynamics
The Nutrigenomics Market is the fastest-moving measurement sub-segment, driven by panels mapping FTO, MTHFR and APOE variants to macronutrient and micronutrient guidance.
The DNA-Based Diet Testing Market is consolidating; panel prices fell roughly 35% between 2021 and 2025 while panel breadth doubled, compressing per-test gross margin to the 45-58% band.
Microbiome sequencing remains the highest-cost, highest-differentiation layer, with kit logistics and cold-chain returns absorbing 8-12% of revenue.
Margin Pressures
Laboratory fixed costs. CLIA and CAP accreditation, plus ISO 15189 alignment, impose multi-hundred-thousand-dollar annual overheads that only scale above roughly 50,000 tests per year.
Reagent dependency. Genotyping arrays and library preparation kits come from a small supplier set, limiting price negotiation leverage for mid-size labs.
Consumable COGS. Capsule and powder fulfillment for personalized SKUs runs at low batch volumes, so unit COGS sits 18-25% above comparable mass-market supplement lines.
Retention economics. Customer acquisition cost in DTC testing has climbed to the USD 90-140 range, making payback periods sensitive to any churn increase.
Primary Market Drivers & Growth Restraints in Personalized Nutrition Market
Market Dynamics Impact Analysis
Factor Type
Description
Impact Level
Timeline
Driver
Genotyping and sequencing cost decline to USD 30-60 per sample
High
Short term
Driver
Rising chronic disease burden, with diabetes prevalence near 11% of adults in key markets
High
Long term
Driver
Subscription recurrence replacing one-time test transactions
High
Short term
Driver
Employer and insurer procurement of wellness nutrition programs
Medium
Long term
Restraint
Ambiguous regulatory classification of combined test-plus-supplement offerings
High
Long term
Restraint
Genetic data consent and cross-border transfer obligations
Medium
Short term
Restraint
DTC retention ceiling near 34% at 12 months
High
Short term
Restraint
Input price volatility in whey, omega-3 and botanical extracts
Medium
Short term
Catalyst Read-Through
Quantitative signals favor the bullish case. A USD 100 reduction in test cost historically correlates with a 12-18% lift in first-time purchase conversion within the same quarter. Meanwhile, clinic-channel integration is becoming a volume driver: dietitian-led protocols in Hospital and Clinics end-use settings are expanding above 15% CAGR, well ahead of the market average.
Bottleneck Read-Through
Regulatory ambiguity is the costliest restraint. A combined genetic test and supplement bundle can be regulated simultaneously as an in-vitro diagnostic, a food supplement and a data-processing activity, tripling compliance overhead. Retention is the second constraint: at 34% 12-month retention, a USD 120 acquisition cost implies a payback window near 19 months on subscription gross margin alone. Input volatility adds a third layer, with whey protein isolate and omega-3 concentrates swinging double digits across recent procurement cycles.
Industrial-scale premix, micronutrient and health ingredient science
B2B supplement and food manufacturers
Leader
BASF SE
Vitamin, carotenoid and omega-3 ingredient portfolios with formulation R&D
B2B formulators and clinical nutrition brands
Leader
Herbalife Nutrition Ltd
Distributor network across 90+ markets with coach-led retention
DTC weight-management and wellness consumers
Leader
Amway
Nutrilite brand equity and global direct-selling infrastructure
DTC and institution-affiliated consumers
Challenger
Balchem Corporation
Encapsulation and chelated mineral technology for bioavailability
B2B nutraceutical and food manufacturers
Challenger
Bactolac Pharmaceutical
Contract manufacturing of personalized supplement SKUs at low minimum order volumes
DTC startups and wellness brands
Niche
DNAfit
Consumer genetic testing with exercise and nutrition trait panels
DTC consumers and corporate wellness buyers
Niche
Atlas Biomed Group Limited
Microbiome and genetic testing with European data residency
EU DTC consumers and research partners
Niche
DSM-Firmenich: anchors the upstream ingredient layer across vitamins, premixes and health ingredients, giving it pricing influence over formulators that lack in-house micronutrient capability.
BASF SE: combines ingredient supply with formulation research, positioning it as a partner of choice for clinical nutrition brands building disease-oriented SKUs.
Herbalife Nutrition Ltd: relies on a coach-mediated distribution model that produces retention metrics above the DTC sector norm.
Amway: leverages the Nutrilite range and distributor relationships to distribute personalized nutrition assessments alongside supplement kits.
Balchem Corporation: supplies encapsulation and chelated mineral systems that improve bioavailability, a differentiating input for premium personalized formats.
Bactolac Pharmaceutical: contract manufacturing partner for small-batch, multi-SKU personalized supplement runs where mass-market manufacturers are uncompetitive.
DNAfit: consumer-facing genetic panels covering nutrition and exercise traits, with a secondary corporate wellness channel.
Atlas Biomed Group Limited: operates microbiome and genetic testing with a European data-residency proposition, addressing GDPR-sensitive buyers.
Habit LLC: combines at-home biomarker collection with coach-supported nutrition planning for DTC subscribers.
wellness coaches usa: delivers practitioner-led coaching and protocol adherence support, an emerging downstream channel for personalized plans.
Strategic Milestones & Recent Developments in Personalized Nutrition Market
The source dataset did not publish a curated developments feed. The table below tracks publicly documented transactions and platform moves that shaped competitive positioning in the current cycle.
Latest Strategic Moves
Date
Company
Event Type
Impact
Nov 2019
Prenetics / DNAfit
M&A
Consolidated consumer genetic testing into a broader diagnostics group
Jan 2020
Viome / Habit LLC
M&A
Added at-home biomarker testing to a microbiome sequencing platform
May 2023
DSM / Firmenich
Merger
Created an ingredient supplier with combined nutrition and health science scale
2021-2023
Amway
Product Launch
Nutrilite personalized nutrition assessments rolled out across multiple markets
2023-2025
Balchem Corporation
Capacity Expansion
Expanded encapsulated and chelated mineral capacity to serve premium formulations
Chronological Detail
2019-2020 consolidation wave. Diagnostics acquirers absorbed consumer testing brands, converting standalone wellness panels into clinical channel entry points. Prenetics and DNAfit, plus Viome and Habit LLC, illustrate the pattern.
2023 upstream realignment. The DSM and Firmenich combination created a supplier with enough scale to influence personalized premix pricing and shorten ingredient development timelines for formulators.
2021-2025 channel broadening. Direct sellers and contract manufacturers moved in opposite directions: Amway pushed consumer-facing assessments, while Bactolac Pharmaceutical scaled low-volume personalized manufacturing for smaller brands.
Forward signal. Retention-focused product design, not panel breadth, now determines which vendors retain subscription revenue past month twelve.
Regional Market Analysis & Growth Corridors for Personalized Nutrition Market
Regional Growth Comparison
Region
Projected CAGR (%)
Base Year Valuation
Primary Catalyst
Regulatory Stringency
North America
10.6%
USD 8.12 Bn
Mature DTC subscriptions and employer wellness procurement
High
Europe
11.2%
USD 5.86 Bn
Nutrigenomic testing adoption and data-residency preference
Very High
Asia-Pacific
14.3%
USD 5.19 Bn
Urban chronic disease burden and mobile-first retail
Moderate to High
South America
12.4%
USD 1.58 Bn
Sports nutrition and clinic channel expansion
Moderate
Middle East & Africa
12.9%
USD 1.80 Bn
Premium wellness spending in the GCC and medical tourism
Moderate
Most Mature Market
North America holds USD 8.12 billion, or 36.0% of global revenue, and grows at a slower 10.6% because the installed base of measured consumers is already large. Growth here is now driven by expansion within existing accounts, corporate wellness contracts and clinic integration rather than new user acquisition.
Fastest-Growing Corridors
Asia-Pacific at 14.3% CAGR. Mobile-first commerce, rising diabetes prevalence and expanding middle-income spending in China, India and ASEAN create the steepest curve in the forecast. China's health food registration pathway remains the primary gating factor.
Middle East & Africa at 12.9% CAGR. GCC premium wellness spending and medical tourism corridors in the UAE and Saudi Arabia support high-ticket personalized programs.
South America at 12.4% CAGR. Sports nutrition demand in Brazil and expanding private clinic networks in Argentina anchor growth, moderated by currency volatility.
Europe at 11.2% CAGR. The Corporate Wellness Nutrition Market is expanding fastest here, since employers absorb the compliance burden of genetic data handling on behalf of individual employees.
Supply Chain & Raw Material Dynamics: Personalized Nutrition Market
The Vitamin and Mineral Supplements Market provides the commodity base layer for personalized SKUs, and its pricing feeds directly into formulation cost. Vitamin D3 and chelated minerals have tracked within a narrow band, but omega-3 concentrates and whey protein isolate remain the two inputs most likely to trigger mid-cycle repricing. Encapsulation partners such as Balchem Corporation mitigate bioavailability risk but add 10-18% to input cost per dose.
The Probiotics Market is structurally tighter than the micronutrient side. A small number of strain patents and culture libraries sit with European and Japanese suppliers, so a single strain disruption can force formulation changes across an entire personalized product line. Genotyping reagents present a similar single-source concentration risk, with library preparation chemistry sourced from a handful of vendors.
Historical Disruption Lessons
2020-2022 logistics shock. Cold-chain kit returns and air freight constraints extended biomarker test turnaround from 5-7 days to 12-18 days in several markets.
2022 dairy protein spike. Whey protein isolate pricing spiked double digits, forcing protein-forward personalized brands to reformulate or absorb margin.
Ongoing mitigation. Vendors are dual-sourcing reagents, shifting to room-temperature collection devices and pre-negotiating annual ingredient contracts to reduce spot exposure.
DSHEA 1994; FDA 21 CFR 111 GMP; CFSAN labeling rules
Supplement claims, manufacturing and labeling
Medium
United States (data)
State genetic privacy statutes such as California SB 41
Consumer genetic data handling and consent
Medium-High
European Union
Regulation 1924/2006 on health claims; IVDR 2017/746; GDPR Article 9
Health claims, diagnostic classification, genetic data
High
United Kingdom
MHRA IVD registration; retained EU health claim rules
Test kit registration and claim substantiation
Medium-High
China
SAMR health food registration (Blue Hat)
Imported and domestic health food approval
High
India
FSSAI Nutraceutical Regulations 2016 and amendments
Nutraceutical composition and labeling
Medium
North America
Structure and function claims remain permissible under DSHEA without pre-market approval, but substantiation files must exist on record. Facilities producing personalized supplement kits fall under 21 CFR 111 GMP, and California SB 41 imposes explicit notice and consent obligations on genetic testing companies handling consumer samples.
Europe
The European Union is the most demanding jurisdiction for this market. Health claims require EFSA authorization under Regulation 1924/2006, genetic test kits are regulated as in-vitro diagnostics under IVDR 2017/746, and genetic data qualifies as a special category under GDPR Article 9. Combined, these frameworks push average time-to-market to 12-24 months for a new test-plus-supplement bundle, and non-EU vendors frequently operate through local legal entities to satisfy data-residency expectations.
Asia-Pacific
China's SAMR registration pathway is the single largest gating item in the region, requiring dossier-based approval for health food claims. Japan's FOSHU system and India's FSSAI framework allow faster entry for standard supplement formats but constrain explicit disease-related claims. Across the region, the compliance trend is toward greater scrutiny of genetic data storage rather than tighter supplement composition rules.
Compliance Outlook
Expect three pressures through 2033: tighter consent and data-transfer requirements for genetic samples, clearer classification of combined diagnostic and supplement offerings, and rising documentation expectations for structured supplement CLAIMS. Vendors that embed regulatory review into product design, rather than retrofitting compliance, will shorten launch cycles by an estimated 4-6 months per product generation.
Personalized Nutrition Market Segmentation
1. Product Type
1.1. Active Measurement
1.2. Standard Measurement
2. Application
2.1. Standard Supplement
2.2. Disease Based
3. End Use
3.1. Direct-to-Consumer
3.2. Wellness and Fitness Centers
3.3. Hospital and Clinics
3.4. Institutions
Personalized Nutrition Market Segmentation By Geography
1. North America
1.1. United States
1.2. Canada
1.3. Mexico
2. South America
2.1. Brazil
2.2. Argentina
2.3. Rest of South America
3. Europe
3.1. United Kingdom
3.2. Germany
3.3. France
3.4. Italy
3.5. Spain
3.6. Russia
3.7. Benelux
3.8. Nordics
3.9. Rest of Europe
4. Middle East & Africa
4.1. Turkey
4.2. Israel
4.3. GCC
4.4. North Africa
4.5. South Africa
4.6. Rest of Middle East & Africa
5. Asia Pacific
5.1. China
5.2. India
5.3. Japan
5.4. South Korea
5.5. ASEAN
5.6. Oceania
5.7. Rest of Asia Pacific
Personalized Nutrition Market REPORT HIGHLIGHTS
Aspects
Details
Study Period
2020-2034
Base Year
2025
Estimated Year
2026
Forecast Period
2026-2034
Historical Period
2020-2025
Growth Rate
CAGR of 11.48% from 2020-2034
Segmentation
By Product Type
Active Measurement
Standard Measurement
By Application
Standard Supplement
Disease Based
By End Use
Direct-to-Consumer
Wellness and Fitness Centers
Hospital and Clinics
Institutions
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
United Kingdom
Germany
France
Italy
Spain
Russia
Benelux
Nordics
Rest of Europe
Middle East & Africa
Turkey
Israel
GCC
North Africa
South Africa
Rest of Middle East & Africa
Asia Pacific
China
India
Japan
South Korea
ASEAN
Oceania
Rest of Asia Pacific
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Objective
1.4. Definitions and Assumptions
2. Executive Summary
2.1. Market Snapshot
3. Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Trends
3.4. Market Opportunity
4. Market Factor Analysis
4.1. Porters Five Forces
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL analysis
4.3. BCG Analysis
4.3.1. Stars (High Growth, High Market Share)
4.3.2. Cash Cows (Low Growth, High Market Share)
4.3.3. Question Mark (High Growth, Low Market Share)
4.3.4. Dogs (Low Growth, Low Market Share)
4.4. Ansoff Matrix Analysis
4.5. Supply Chain Analysis
4.6. Regulatory Landscape
4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
4.8. MIQ Analyst Note
5. Market Analysis, Insights and Forecast, 2020-2034
5.1. Market Analysis, Insights and Forecast - by Product Type
5.1.1. Active Measurement
5.1.2. Standard Measurement
5.2. Market Analysis, Insights and Forecast - by Application
5.2.1. Standard Supplement
5.2.2. Disease Based
5.3. Market Analysis, Insights and Forecast - by End Use
5.3.1. Direct-to-Consumer
5.3.2. Wellness and Fitness Centers
5.3.3. Hospital and Clinics
5.3.4. Institutions
5.4. Market Analysis, Insights and Forecast - by Region
5.4.1. North America
5.4.2. South America
5.4.3. Europe
5.4.4. Middle East & Africa
5.4.5. Asia Pacific
6. North America Market Analysis, Insights and Forecast, 2020-2034
6.1. Market Analysis, Insights and Forecast - by Product Type
6.1.1. Active Measurement
6.1.2. Standard Measurement
6.2. Market Analysis, Insights and Forecast - by Application
6.2.1. Standard Supplement
6.2.2. Disease Based
6.3. Market Analysis, Insights and Forecast - by End Use
6.3.1. Direct-to-Consumer
6.3.2. Wellness and Fitness Centers
6.3.3. Hospital and Clinics
6.3.4. Institutions
7. South America Market Analysis, Insights and Forecast, 2020-2034
7.1. Market Analysis, Insights and Forecast - by Product Type
7.1.1. Active Measurement
7.1.2. Standard Measurement
7.2. Market Analysis, Insights and Forecast - by Application
7.2.1. Standard Supplement
7.2.2. Disease Based
7.3. Market Analysis, Insights and Forecast - by End Use
7.3.1. Direct-to-Consumer
7.3.2. Wellness and Fitness Centers
7.3.3. Hospital and Clinics
7.3.4. Institutions
8. Europe Market Analysis, Insights and Forecast, 2020-2034
8.1. Market Analysis, Insights and Forecast - by Product Type
8.1.1. Active Measurement
8.1.2. Standard Measurement
8.2. Market Analysis, Insights and Forecast - by Application
8.2.1. Standard Supplement
8.2.2. Disease Based
8.3. Market Analysis, Insights and Forecast - by End Use
8.3.1. Direct-to-Consumer
8.3.2. Wellness and Fitness Centers
8.3.3. Hospital and Clinics
8.3.4. Institutions
9. Middle East & Africa Market Analysis, Insights and Forecast, 2020-2034
9.1. Market Analysis, Insights and Forecast - by Product Type
9.1.1. Active Measurement
9.1.2. Standard Measurement
9.2. Market Analysis, Insights and Forecast - by Application
9.2.1. Standard Supplement
9.2.2. Disease Based
9.3. Market Analysis, Insights and Forecast - by End Use
9.3.1. Direct-to-Consumer
9.3.2. Wellness and Fitness Centers
9.3.3. Hospital and Clinics
9.3.4. Institutions
10. Asia Pacific Market Analysis, Insights and Forecast, 2020-2034
10.1. Market Analysis, Insights and Forecast - by Product Type
10.1.1. Active Measurement
10.1.2. Standard Measurement
10.2. Market Analysis, Insights and Forecast - by Application
10.2.1. Standard Supplement
10.2.2. Disease Based
10.3. Market Analysis, Insights and Forecast - by End Use
10.3.1. Direct-to-Consumer
10.3.2. Wellness and Fitness Centers
10.3.3. Hospital and Clinics
10.3.4. Institutions
11. Competitive Analysis
11.1. Company Profiles
11.1.1. Balchem Corporation
11.1.1.1. Company Overview
11.1.1.2. Products
11.1.1.3. Company Financials
11.1.1.4. SWOT Analysis
11.1.2. Atlas Biomed Group Limited
11.1.2.1. Company Overview
11.1.2.2. Products
11.1.2.3. Company Financials
11.1.2.4. SWOT Analysis
11.1.3. Bactolac Pharmaceutical
11.1.3.1. Company Overview
11.1.3.2. Products
11.1.3.3. Company Financials
11.1.3.4. SWOT Analysis
11.1.4. DNAfit
11.1.4.1. Company Overview
11.1.4.2. Products
11.1.4.3. Company Financials
11.1.4.4. SWOT Analysis
11.1.5. DSM
11.1.5.1. Company Overview
11.1.5.2. Products
11.1.5.3. Company Financials
11.1.5.4. SWOT Analysis
11.1.6. Habit
11.1.6.1. Company Overview
11.1.6.2. Products
11.1.6.3. Company Financials
11.1.6.4. SWOT Analysis
11.1.7. LLC
11.1.7.1. Company Overview
11.1.7.2. Products
11.1.7.3. Company Financials
11.1.7.4. SWOT Analysis
11.1.8. Amway
11.1.8.1. Company Overview
11.1.8.2. Products
11.1.8.3. Company Financials
11.1.8.4. SWOT Analysis
11.1.9. BASF SE
11.1.9.1. Company Overview
11.1.9.2. Products
11.1.9.3. Company Financials
11.1.9.4. SWOT Analysis
11.1.10. Herbalife Nutrition Ltd
11.1.10.1. Company Overview
11.1.10.2. Products
11.1.10.3. Company Financials
11.1.10.4. SWOT Analysis
11.1.11. wellness coaches usa
11.1.11.1. Company Overview
11.1.11.2. Products
11.1.11.3. Company Financials
11.1.11.4. SWOT Analysis
11.2. Market Entropy
11.2.1. Company's Key Areas Served
11.2.2. Recent Developments
11.3. Company Market Share Analysis, 2026
11.3.1. Top 5 Companies Market Share Analysis
11.3.2. Top 3 Companies Market Share Analysis
11.4. List of Potential Customers
12. Research Methodology
List of Figures
Figure 1: Personalized Nutrition Market Revenue Breakdown (billion, %) by Region 2026 & 2034
Figure 2: North America Personalized Nutrition Market Revenue (billion), by Product Type 2026 & 2034
Figure 3: North America Personalized Nutrition Market Revenue Share (%), by Product Type 2026 & 2034
Figure 4: North America Personalized Nutrition Market Revenue (billion), by Application 2026 & 2034
Figure 5: North America Personalized Nutrition Market Revenue Share (%), by Application 2026 & 2034
Figure 6: North America Personalized Nutrition Market Revenue (billion), by End Use 2026 & 2034
Figure 7: North America Personalized Nutrition Market Revenue Share (%), by End Use 2026 & 2034
Figure 8: North America Personalized Nutrition Market Revenue (billion), by Country 2026 & 2034
Figure 9: North America Personalized Nutrition Market Revenue Share (%), by Country 2026 & 2034
Figure 10: South America Personalized Nutrition Market Revenue (billion), by Product Type 2026 & 2034
Figure 11: South America Personalized Nutrition Market Revenue Share (%), by Product Type 2026 & 2034
Figure 12: South America Personalized Nutrition Market Revenue (billion), by Application 2026 & 2034
Figure 13: South America Personalized Nutrition Market Revenue Share (%), by Application 2026 & 2034
Figure 14: South America Personalized Nutrition Market Revenue (billion), by End Use 2026 & 2034
Figure 15: South America Personalized Nutrition Market Revenue Share (%), by End Use 2026 & 2034
Figure 16: South America Personalized Nutrition Market Revenue (billion), by Country 2026 & 2034
Figure 17: South America Personalized Nutrition Market Revenue Share (%), by Country 2026 & 2034
Figure 18: Europe Personalized Nutrition Market Revenue (billion), by Product Type 2026 & 2034
Figure 19: Europe Personalized Nutrition Market Revenue Share (%), by Product Type 2026 & 2034
Figure 20: Europe Personalized Nutrition Market Revenue (billion), by Application 2026 & 2034
Figure 21: Europe Personalized Nutrition Market Revenue Share (%), by Application 2026 & 2034
Figure 22: Europe Personalized Nutrition Market Revenue (billion), by End Use 2026 & 2034
Figure 23: Europe Personalized Nutrition Market Revenue Share (%), by End Use 2026 & 2034
Figure 24: Europe Personalized Nutrition Market Revenue (billion), by Country 2026 & 2034
Figure 25: Europe Personalized Nutrition Market Revenue Share (%), by Country 2026 & 2034
Figure 26: Middle East & Africa Personalized Nutrition Market Revenue (billion), by Product Type 2026 & 2034
Figure 27: Middle East & Africa Personalized Nutrition Market Revenue Share (%), by Product Type 2026 & 2034
Figure 28: Middle East & Africa Personalized Nutrition Market Revenue (billion), by Application 2026 & 2034
Figure 29: Middle East & Africa Personalized Nutrition Market Revenue Share (%), by Application 2026 & 2034
Figure 30: Middle East & Africa Personalized Nutrition Market Revenue (billion), by End Use 2026 & 2034
Figure 31: Middle East & Africa Personalized Nutrition Market Revenue Share (%), by End Use 2026 & 2034
Figure 32: Middle East & Africa Personalized Nutrition Market Revenue (billion), by Country 2026 & 2034
Figure 33: Middle East & Africa Personalized Nutrition Market Revenue Share (%), by Country 2026 & 2034
Figure 34: Asia Pacific Personalized Nutrition Market Revenue (billion), by Product Type 2026 & 2034
Figure 35: Asia Pacific Personalized Nutrition Market Revenue Share (%), by Product Type 2026 & 2034
Figure 36: Asia Pacific Personalized Nutrition Market Revenue (billion), by Application 2026 & 2034
Figure 37: Asia Pacific Personalized Nutrition Market Revenue Share (%), by Application 2026 & 2034
Figure 38: Asia Pacific Personalized Nutrition Market Revenue (billion), by End Use 2026 & 2034
Figure 39: Asia Pacific Personalized Nutrition Market Revenue Share (%), by End Use 2026 & 2034
Figure 40: Asia Pacific Personalized Nutrition Market Revenue (billion), by Country 2026 & 2034
Figure 41: Asia Pacific Personalized Nutrition Market Revenue Share (%), by Country 2026 & 2034
List of Tables
Table 1: Personalized Nutrition Market Revenue billion Forecast, by Product Type 2020 & 2034
Table 52: Rest of Asia Pacific Personalized Nutrition Market Revenue (billion) Forecast, by Application 2020 & 2034
Research Methodology & Data Sources
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
Primary Research
Primary research accounts for 70-80% of total effort, with 20-30% derived from secondary sources. Fieldwork is executed across the full personalized nutrition value chain rather than at aggregate category level.
Interview targets include: nutrigenomic testing laboratory directors and CLIA/CAP-accredited lab operations leads; personalized supplement contract manufacturers (nutraceutical CDMOs) producing low-MOQ custom SKUs; direct-to-consumer subscription platform operators managing retention and fulfillment; wearable and continuous glucose monitor OEMs supplying biomarker telemetry; and specialty micronutrient, probiotic and omega-3 ingredient distributors.
Specialty Micronutrient, Probiotic and Omega-3 Ingredient Suppliers
16%
Secondary Research & Industry Benchmarking
Financial and transaction data is sourced from Bloomberg, Factiva, Hoovers, and PitchBook for company financials, M&A activity and venture funding rounds.
Government and association sources include FDA.gov, EFSA.europa.eu, SEC EDGAR, and trade association publications from CRN and ASN. Market research reseller websites are explicitly excluded from citation.
All datasets are refreshed to the date of purchase, so every delivered report reflects the latest available filings and announcements.
Demand Modeling & Market Estimation
Top-down and bottom-up models are built simultaneously and reconciled through multi-level data triangulation before any figure is published.
Bottom-up quantitative inputs include: number of consumer genetic and microbiome tests sold annually by channel and price band; average revenue per subscriber per month across DTC personalized nutrition plans; share of hospital and clinic dietetics departments deploying biomarker-driven supplement protocols; and per-sample reagent and consumable cost for array and sequencing panels.
Segment splits are validated against published revenue of named vendors in Product Type, Application and End Use categories, with residual variance allocated using channel-weighted growth rates.
Regional models are built from country-level unit volumes and price bands for North America, South America, Europe, Middle East & Africa, and Asia Pacific, then aggregated to global totals.
Data Accuracy & Quality Check
Every estimate carries a guaranteed accuracy level of 85-90%, with confidence intervals widened where primary response coverage is below 60% of the sampled universe.
Triangulation is performed across three independent layers: primary interview transcripts, vendor financial disclosures, and official trade and regulatory statistics.
Outlier responses are re-contacted and cross-checked against at least two independent sources before inclusion.
Final figures are reviewed by a senior analyst panel for internal consistency across segments, regions and time series prior to publication.
Frequently Asked Questions
1. What are the main product types and applications in the Personalized Nutrition Market?
The market splits by product type into Active Measurement, which held USD 13.17 billion, or 58.4% of 2025 revenue, and Standard Measurement at 41.6%. By application, Standard Supplement formats remain the revenue base while Disease Based protocols for diabetes and cardiometabolic care grow fastest at 14.6% CAGR. End use divides across Direct-to-Consumer, Wellness and Fitness Centers, Hospital and Clinics, and Institutions.
2. How are technological innovations reshaping personalized nutrition testing?
Array-based genotyping and targeted sequencing now cost roughly USD 30-60 per sample at commercial volume, which pushed consumer panel pricing below USD 200 in North America. Continuous glucose monitors, wearables and microbiome shotgun sequencing feed recommendation engines that adjust supplement stacks month to month. Companies such as DNAfit and Atlas Biomed Group Limited combine genetic trait panels with coaching workflows to lift retention.
3. How much venture capital and investment activity is flowing into this sector?
Investment is concentrated in measurement platforms rather than manufacturing. Zoe Global raised USD 15 million in its 2019 Series A, and Prenetics acquired DNAfit in 2019 in a transaction reported near USD 25 million. Strategic acquirers including Nestlé Health Science and Viome have bought DTC testing assets to bolt nutrition protocols onto existing clinical channels.
4. Who are the leading companies and how concentrated is the competitive landscape?
No single vendor holds more than roughly 8% of global revenue, so the market remains fragmented. DSM-Firmenich and BASF SE control ingredient supply, Herbalife Nutrition Ltd and Amway own large distributor networks, and Balchem Corporation supplies encapsulation and chelated mineral technology. Testing specialists such as DNAfit, Habit LLC and Atlas Biomed Group Limited compete on panel breadth and data privacy rather than scale.
5. What barriers to entry and competitive moats protect incumbent positions?
Clinical-grade laboratory accreditation under CLIA and CAP, plus EU IVDR conformity for genetic test kits, requires capital and 12-24 months of validation work. Incumbent moats rest on proprietary genotype-phenotype datasets, ingredient patent estates and distribution reach, not on formulation alone. Customer trust and consent management under GDPR Article 9 add a compliance barrier that small entrants frequently underestimate.
6. Which end-user industries drive downstream demand and where is it shifting?
Direct-to-Consumer channels generate about 46% of personalized nutrition revenue, followed by Wellness and Fitness Centers and Institutions. Hospital and Clinics represent the fastest-growing end-use, expanding above 15% CAGR as dietitians integrate biomarker-driven supplement protocols into chronic disease management. Corporate wellness procurement is emerging as a volume channel because employers buy subscriptions in blocks of thousands of seats.
